Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Methylprednisolone on Treatment of COVID-19
IRCT20200404046947N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of methylprednisolone in coronavirus disease 2019 (COVID-19), sponsored by Tehran University of Medical Sciences. Started Mar 2020; status: completed.
02
Drugs
methylprednisolone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200404046947N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200404046947N1.